Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Cozzi

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Radiation Oncology (London, England)|September 14, 2011
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatmentsMarta Scorsetti, Filippo Alongi, Simona Castiglioni, et al.
Oncotarget|October 6, 2017
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II studyPierina Navarria, Federico Pessina, Stefano Tomatis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2011
Vertebral metastases reirradiation with volumetric-modulated arc radiotherapyPierina Navarria, Pietro Mancosu, Filippo Alongi, et al.
Plos One|January 19, 2019
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinomaLuca Cozzi, Tiziana Comito, Antonella Fogliata, et al.
Clinical Breast Cancer|July 16, 2020
Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and CosmesisFiorenza De Rose, Antonella Fogliata, Davide Franceschini, et al.
Anticancer Research|July 1, 2015
Neoadjuvant Chemoradiotherapy with Volumetric-modulated Arc Therapy for Medium-distal Oesophageal and Gastro-oesophageal Junction CarcinomaAngelo Tozzi, Cristina Iftode, Luca Cozzi, et al.
BMC Cancer|August 29, 2014
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approachTiziana Comito, Luca Cozzi, Elena Clerici, et al.
Journal of Medical Imaging and Radiation Sciences|June 3, 2026
Dosimetric evaluation and clinical feasibility of Halcyon-E O-ring linear accelerator for single fraction coplanar stereotactic radiosurgeryTanweer Shahid, Biplab Sarkar, Subhra Singdha Biswal, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 24, 2004
Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trialAugusto Gallino, Dai-Do Do, Mario Alerci, et al.
Radiation Oncology (London, England)|August 30, 2012
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatmentsMarta Scorsetti, Filippo Alongi, Antonella Fogliata, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Radiation Oncology (London, England)|September 14, 2011
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatmentsMarta Scorsetti, Filippo Alongi, Simona Castiglioni, et al.
Oncotarget|October 6, 2017
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II studyPierina Navarria, Federico Pessina, Stefano Tomatis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2011
Vertebral metastases reirradiation with volumetric-modulated arc radiotherapyPierina Navarria, Pietro Mancosu, Filippo Alongi, et al.
Plos One|January 19, 2019
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinomaLuca Cozzi, Tiziana Comito, Antonella Fogliata, et al.
Clinical Breast Cancer|July 16, 2020
Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and CosmesisFiorenza De Rose, Antonella Fogliata, Davide Franceschini, et al.
Anticancer Research|July 1, 2015
Neoadjuvant Chemoradiotherapy with Volumetric-modulated Arc Therapy for Medium-distal Oesophageal and Gastro-oesophageal Junction CarcinomaAngelo Tozzi, Cristina Iftode, Luca Cozzi, et al.
BMC Cancer|August 29, 2014
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approachTiziana Comito, Luca Cozzi, Elena Clerici, et al.
Journal of Medical Imaging and Radiation Sciences|June 3, 2026
Dosimetric evaluation and clinical feasibility of Halcyon-E O-ring linear accelerator for single fraction coplanar stereotactic radiosurgeryTanweer Shahid, Biplab Sarkar, Subhra Singdha Biswal, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 24, 2004
Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trialAugusto Gallino, Dai-Do Do, Mario Alerci, et al.
Radiation Oncology (London, England)|August 30, 2012
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatmentsMarta Scorsetti, Filippo Alongi, Antonella Fogliata, et al.
Pageof 21